Search Results

There are 6103 results for: content related to: The Loss of Homeostasis in Hemostasis: New Approaches in Treating and Understanding Acute Disseminated Intravascular Coagulation in Critically Ill Patients *

  1. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients

    Intervention Review

    The Cochrane Library

    Arturo J Martí-Carvajal, Ivan Solà, Christian Gluud, Dimitrios Lathyris and Andrés Felipe Cardona

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD004388.pub6

  2. Current Issues Regarding the Use of Drotrecogin alfa (activated)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 12P2, December 2002, Pages: 206S–215S, Dr. Erkan Hassan and Dr. Henry J. Mann

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.18.206S.33707

  3. Strategies to Optimize Drotrecogin alfa (activated) Use: Guidelines and Therapeutic Controversies

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 12P2, December 2002, Pages: 223S–235S, Dr. Henry Cohen and Dr. Lynda S. Welage

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.18.223S.33706

  4. Pharmacokinetics and Clinical Use of Drotrecogin alfa (activated) in Patients with Severe Sepsis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 12P2, December 2002, Pages: 196S–205S, Dr. Keith M. Olsen and Dr. Steven J. Martin

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.18.196S.33708

  5. Pharmacology, Clinical Efficacy, and Safety of Drotrecogin alfa (activated)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 12P2, December 2002, Pages: 182S–195S, Maria I. Rudis and Douglas N. Fish

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.18.182S.33704

  6. Cochrane review: Human recombinant activated protein C for severe sepsis

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 3, Issue 1, March 2008, Pages: 86–138, Prof A Martí-Carvajal, G Salanti and AF Cardona

    Article first published online : 26 MAR 2008, DOI: 10.1002/ebch.210

  7. Drotrecogin alfa: A role in emergency department treatment of severe sepsis?

    Emergency Medicine

    Volume 16, Issue 4, August 2004, Pages: 324–335, Adam M McLeay

    Article first published online : 28 JUL 2004, DOI: 10.1111/j.1742-6723.2004.00630.x

  8. Use of Drotrecogin alfa (activated) in Older Patients with Severe Sepsis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 4, April 2006, Pages: 533–538, Dr. Sherri L. Alexander and Dr. Frank R. Ernst

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.26.4.533

  9. Recombinant Human Activated Protein C, Drotrecogin Alfa (activated): A Novel Therapy for Severe Sepsis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 11, November 2001, Pages: 1389–1402, Dr. Salmaan Kanji, Dr. John W. Devlin, Dr. Krista A. Piekos and Dr. Eric Racine

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.21.17.1389.34417

  10. Challenge and Rechallenge: Drotrecogin alfa (activated)–Induced Prolongation of Activated Partial Thromboplastin Time in a Patient with Severe Sepsis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 8, August 2005, Pages: 1147–1150, Dr. Emily E. Castelli, Dr. Colleen M. Culley and Dr. Mitchell P. Fink

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.8.1147

  11. Recombinant human activated protein C for severe sepsis in neonates

    Intervention Review

    The Cochrane Library

    Ranjit I Kylat and Arne Ohlsson

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD005385.pub3

  12. Predictors of Hospital Mortality for Patients with Severe Sepsis Treated with Drotrecogin alfa (activated)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 1, January 2005, Pages: 26–34, Dr. Scott T. Micek, Dr. Warren Isakow, Dr. William Shannon and Dr. Marin H. Kollef

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.25.1.26.55615

  13. You have free access to this content
    Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom*

    Anaesthesia

    Volume 60, Issue 2, February 2005, Pages: 155–162, A. Davies, S. Ridley, J. Hutton, C. Chinn, B. Barber and D. C. Angus

    Article first published online : 10 JAN 2005, DOI: 10.1111/j.1365-2044.2004.04068.x

  14. You have free access to this content
    Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 11, November 2004, Pages: 1924–1933, J.-F. Dhainaut, S. B. Yan, D. E. Joyce, V. Pettilä, B. Basson, J. T. Brandt, D. P. Sundin and M. Levi

    Article first published online : 6 OCT 2004, DOI: 10.1111/j.1538-7836.2004.00955.x

  15. You have free access to this content
    Protective mechanisms of activated protein C in severe inflammatory disorders

    British Journal of Pharmacology

    Volume 158, Issue 4, October 2009, Pages: 1034–1047, Arne P Neyrinck, Kathleen D Liu, James P Howard and Michael A Matthay

    Article first published online : 18 MAY 2009, DOI: 10.1111/j.1476-5381.2009.00251.x

  16. Management of Severe Sepsis: Integration of Multiple Pharmacologic Interventions

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 11, November 2003, Pages: 1486–1496, Dr. Scott T. Micek, Dr. Rina A. Shah and Dr. Marin H. Kollef

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.23.14.1486.31945

  17. You have free access to this content
    Activated protein C in sepsis

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 5, May 2004, Pages: 708–717, F. B. Taylor and G. Kinasewitz

    Article first published online : 6 APR 2004, DOI: 10.1111/j.1538-7836.2004.00751.x

  18. Experience with Drotrecogin in Two Australian Hospitals

    Journal of Pharmacy Practice and Research

    Volume 36, Issue 3, September 2006, Pages: 185–186, Fraser D Mackenzie, Peter I Pillans, David A Cook, Alexander E Dixon and Paul A Kubler

    Article first published online : 13 APR 2015, DOI: 10.1002/j.2055-2335.2006.tb00603.x

  19. Treatment of Heparin-Induced Thrombocytopenia with Drotrecogin Alfa (activated)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 3, March 2006, Pages: 428–434, Dr. George J. Rubeiz, Dr. Christopher M. Marrone and Dr. Jacques R. Leclerc

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.26.3.428

  20. Implementation of sepsis management guideline in a community-based teaching hospital – can education be potentially beneficial for septic patients?

    International Journal of Clinical Practice

    Volume 66, Issue 7, July 2012, Pages: 705–710, H. M. Nguyen, A. Schiavoni, K. D. Scott and M. A. Tanios

    Article first published online : 15 JUN 2012, DOI: 10.1111/j.1742-1241.2012.02939.x